These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7848122)
1. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Marder K; Richards M; Bello J; Bell K; Sano M; Miller L; Folstein M; Albert M; Stern Y Arch Neurol; 1995 Feb; 52(2):146-51. PubMed ID: 7848122 [TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and the severity of dementia in older adults. Bondareff W; Raval J; Woo B; Hauser DL; Colletti PM Arch Gen Psychiatry; 1990 Jan; 47(1):47-51. PubMed ID: 2294855 [TBL] [Abstract][Full Text] [Related]
3. [Clinical presentation of Moroccan cases with Alzheimer's disease]. El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896 [TBL] [Abstract][Full Text] [Related]
5. Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics. Fitten LJ; Ortiz F; Pontón M J Am Geriatr Soc; 2001 Oct; 49(10):1301-8. PubMed ID: 11890488 [TBL] [Abstract][Full Text] [Related]
6. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. Starkstein SE; Sabe L; Vázquez S; Di Lorenzo G; Martínez A; Petracca G; Tesón A; Chemerinski E; Leiguarda R J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):66-73. PubMed ID: 9221970 [TBL] [Abstract][Full Text] [Related]
7. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction. Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094 [TBL] [Abstract][Full Text] [Related]
8. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography. Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834 [TBL] [Abstract][Full Text] [Related]
9. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442 [TBL] [Abstract][Full Text] [Related]
10. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Erkinjuntti T; Gao F; Lee DH; Eliasziw M; Merskey H; Hachinski VC Arch Neurol; 1994 Mar; 51(3):260-8. PubMed ID: 8129637 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia. Kertesz A; Clydesdale S Arch Neurol; 1994 Dec; 51(12):1226-31. PubMed ID: 7986178 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls. Sandor T; Jolesz F; Tieman J; Kikinis R; Jones K; Albert M Arch Neurol; 1992 Apr; 49(4):381-4. PubMed ID: 1558519 [TBL] [Abstract][Full Text] [Related]
13. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Leys D; Soetaert G; Petit H; Fauquette A; Pruvo JP; Steinling M Arch Neurol; 1990 May; 47(5):524-7. PubMed ID: 2334300 [TBL] [Abstract][Full Text] [Related]
14. Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease. Lopez OL; Brenner RP; Becker JT; Jungreis CA; Rezek D; DeKosky ST Dementia; 1995; 6(6):343-7. PubMed ID: 8563788 [TBL] [Abstract][Full Text] [Related]
15. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. Modrego PJ; Pina MA; Fayed N; Díaz M CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455 [TBL] [Abstract][Full Text] [Related]
16. Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT. Levy-Cooperman N; Lobaugh NJ; Caldwell C; Gao F; Black SE Dement Geriatr Cogn Disord; 2007; 24(5):380-8. PubMed ID: 17934273 [TBL] [Abstract][Full Text] [Related]
17. Does computed tomographic brain imaging have a place in the diagnosis of dementia? Engel PA; Gelber J Arch Intern Med; 1992 Jul; 152(7):1437-40. PubMed ID: 1627022 [TBL] [Abstract][Full Text] [Related]
18. Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease. Sullivan EV; Shear PK; Mathalon DH; Lim KO; Yesavage JA; Tinklenberg JR; Pfefferbaum A Arch Neurol; 1993 Apr; 50(4):359-73. PubMed ID: 8460957 [TBL] [Abstract][Full Text] [Related]
19. Use of structural imaging to study the progression of Alzheimer's disease. Smith AD; Jobst KA Br Med Bull; 1996 Jul; 52(3):575-86. PubMed ID: 8949258 [TBL] [Abstract][Full Text] [Related]
20. Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Schmand B; Eikelenboom P; van Gool WA; J Am Geriatr Soc; 2011 Sep; 59(9):1705-10. PubMed ID: 21883100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]